Potassium canrenoate

Potassium canrenoate

Clinical data
Routes of administration	Intravenous
ATC code	C03DA02 (WHO)
Pharmacokinetic data
Metabolism	Hepatic
Excretion	Renal and fecal
Identifiers
IUPAC name potassium 3-[(8R,9S,10R,13S,14S,17R)- 17-hydroxy-10,13-dimethyl-3-oxo-2,8,9, 11,12,14,15,16-octahydro-1H-cyclopenta[a] phenanthren-17-yl]propanoate
PubChem CID	656614
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C22H29KO4
Molar mass	369.516 g/mol

WikiDoc Resources for Potassium canrenoate
Articles
Most recent articles on Potassium canrenoate Most cited articles on Potassium canrenoate Review articles on Potassium canrenoate Articles on Potassium canrenoate in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Potassium canrenoate Images of Potassium canrenoate Photos of Potassium canrenoate Podcasts & MP3s on Potassium canrenoate Videos on Potassium canrenoate
Evidence Based Medicine
Cochrane Collaboration on Potassium canrenoate Bandolier on Potassium canrenoate TRIP on Potassium canrenoate
Clinical Trials
Ongoing Trials on Potassium canrenoate at Clinical Trials.gov Trial results on Potassium canrenoate Clinical Trials on Potassium canrenoate at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Potassium canrenoate NICE Guidance on Potassium canrenoate NHS PRODIGY Guidance FDA on Potassium canrenoate CDC on Potassium canrenoate
Books
Books on Potassium canrenoate
News
Potassium canrenoate in the news Be alerted to news on Potassium canrenoate News trends on Potassium canrenoate
Commentary
Blogs on Potassium canrenoate
Definitions
Definitions of Potassium canrenoate
Patient Resources / Community
Patient resources on Potassium canrenoate Discussion groups on Potassium canrenoate Patient Handouts on Potassium canrenoate Directions to Hospitals Treating Potassium canrenoate Risk calculators and risk factors for Potassium canrenoate
Healthcare Provider Resources
Symptoms of Potassium canrenoate Causes & Risk Factors for Potassium canrenoate Diagnostic studies for Potassium canrenoate Treatment of Potassium canrenoate
Continuing Medical Education (CME)
CME Programs on Potassium canrenoate
International
Potassium canrenoate en Espanol Potassium canrenoate en Francais
Business
Potassium canrenoate in the Marketplace Patents on Potassium canrenoate
Experimental / Informatics
List of terms related to Potassium canrenoate

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Potassium canrenoate (INN) or canrenoate potassium (USAN), the potassium salt of canrenoic acid, is an aldosterone antagonist. Like spironolactone, it is a prodrug, which is metabolized to canrenone in the body.

See Also

• Canrenone
• Spironolactone